StemCyte International, Ltd. (4178.TWO)
Key Executives
Key Executives Information Not Available
StemCyte International, Ltd.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
StemCyte International, Ltd. operates cord blood cell banks in the United States and Taiwan. It supplies cord blood to medical centers for transplantation in the treatment of blood system diseases; and provides cord blood supply, mononuclear cell supply, and immune cell supply services. The company also develops cord blood to treat COVID-19 syndrome and acute ischemic stroke; and CB201, an immune cell drug. In addition, it offers cord blood storage, immune cell storage, and cord blood cell bank transplant cell services. The company was founded in 2013 and is based in Taipei, Taiwan.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available